ASCO Education

191 Episodio

1. Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

   Pubblicato: 27/06/2018
2. Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

   Pubblicato: 20/06/2018
3. ASCO Guideline: Fertility Preservation in Patients with Cancer

   Pubblicato: 13/06/2018
4. Self-Evaluation: EGFR Mutation

   Pubblicato: 06/06/2018
5. Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

   Pubblicato: 30/05/2018
6. ASCO Guidelines: Outpatient Management of Fever and Neutropenia

   Pubblicato: 23/05/2018
7. Self-Evaluation: NSCLC Treatment Metastatic

   Pubblicato: 16/05/2018
8. Adjuvant Treatment in Melanoma: Recent Advances

   Pubblicato: 09/05/2018
9. Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

   Pubblicato: 02/05/2018
10. Guidelines: Management of Immune-Related Adverse Events

    Pubblicato: 25/04/2018
11. Treatment Effects & Transition to Survivorship for AYA Patients

    Pubblicato: 18/04/2018
12. EHR Chemotherapy Error: Breast Cancer

    Pubblicato: 11/04/2018
13. Continuity of Care for AYAs

    Pubblicato: 04/04/2018
14. Self-Evaluation: Clinical Trials Informed Consent Process

    Pubblicato: 28/03/2018
15. Self-Evaluation: Clinical Trials

    Pubblicato: 14/03/2018
16. Self-Evaluation: NSCLC

    Pubblicato: 14/02/2018
17. Self-Evaluation: Breast Cancer

    Pubblicato: 07/02/2018
18. Self-Evaluation: Metastatic Breast Cancer

    Pubblicato: 13/12/2017
19. ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

    Pubblicato: 06/12/2017
20. Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

    Pubblicato: 22/11/2017